scholarly journals Real-time RT-PCR for H5N1 avian influenza A virus detection

2007 ◽  
Vol 56 (5) ◽  
pp. 603-607 ◽  
Author(s):  
Weijun Chen ◽  
Bo He ◽  
Changgui Li ◽  
Xiaowei Zhang ◽  
Weili Wu ◽  
...  

The recent recurrence of highly pathogenic avian influenza virus A H5N1 was firstly reported in mid-December 2003 and continued through 2005. This study describes a sensitive and specific real-time RT-PCR method for the detection of influenza A subtype H5 and for monitoring virus loads. Using serial dilutions of influenza A H5N1 cultures, this assay reproducibly determined the lowest detection limit to be approximately 5×10−2 50 % egg infective doses (EID50). In contrast, the minimum detection limit was approximately 3 EID50 in conventional RT-PCR with WHO primers and 10 EID50 in antigen-capture ELISA. In tests of serial dilutions of in vitro-transcribed influenza A H5 gene RNA, there was linear amplification from 40 copies to 4×108 copies of target RNA per reaction and approximately six copies, and sometimes even as few as three copies, of target RNA tested positive in our assay. Thirty-five throat swabs from ill birds were tested: 33 samples tested positive using this assay. In comparison, 27, 13 and 19 samples tested positive using conventional RT-PCR, antigen-capture ELISA and virus isolation, respectively. To evaluate further the sensitivity of this real-time RT-PCR, a standard panel and 60 H5N1 isolates that contained different clades of influenza virus A/H5N1 were tested and all tested positive. To evaluate the specificity of the assay, 60 throat swabs from patients infected with influenza virus A H1 were tested; all were negative. Thirteen other viruses were also tested and all tested negative.

2021 ◽  
pp. 104063872199481
Author(s):  
Yixin Xiao ◽  
Fan Yang ◽  
Fumin Liu ◽  
Hangping Yao ◽  
Nanping Wu ◽  
...  

The H2 subtypes of avian influenza A viruses (avian IAVs) have been circulating in poultry, and they have the potential to infect humans. Therefore, establishing a method to quickly detect this subtype is pivotal. We developed a TaqMan minor groove binder real-time RT-PCR assay that involved probes and primers based on conserved sequences of the matrix and hemagglutinin genes. The detection limit of this assay was as low as one 50% egg infectious dose (EID50)/mL per reaction. This assay is specific, sensitive, and rapid for detecting avian IAV H2 subtypes.


2014 ◽  
Vol 6 (8) ◽  
pp. 2628 ◽  
Author(s):  
Ling Zhu ◽  
Cancan Zhu ◽  
Guoqing Deng ◽  
Long Zhang ◽  
Shumi Zhao ◽  
...  

2007 ◽  
Vol 2 (s1) ◽  
pp. e13-e13
Author(s):  
Montserrat Agüero ◽  
Elena San Miguel ◽  
Azucena Sánchez ◽  
Concepción Gómez-Tejedor ◽  
Miguel Angel Jiménez-Clavero

2003 ◽  
Vol 47 (s3) ◽  
pp. 1079-1082 ◽  
Author(s):  
E. Spackman ◽  
D. A. Senne ◽  
L. L. Bulaga ◽  
T. J. Myers ◽  
M. L. Perdue ◽  
...  

2007 ◽  
Vol 40 (2) ◽  
pp. 142-145 ◽  
Author(s):  
Deepanker Tewari ◽  
Corey Zellers ◽  
Helen Acland ◽  
Janice C. Pedersen

2014 ◽  
Vol 19 (4) ◽  
Author(s):  
E Broberg ◽  
D Pereyaslov ◽  
M Struelens ◽  
D Palm ◽  
A Meijer ◽  
...  

Following human infections with novel avian influenza A(H7N9) viruses in China, the European Centre for Disease Prevention and Control, the World Health Organization (WHO) Regional Office for Europe and the European Reference Laboratory Network for Human Influenza (ERLI-Net) rapidly posted relevant information, including real-time RT-PCR protocols. An influenza RNA sequence-based computational assessment of detection capabilities for this virus was conducted in 32 national influenza reference laboratories in 29 countries, mostly WHO National Influenza Centres participating in the WHO Global Influenza Surveillance and Response System (GISRS). Twenty-seven countries considered their generic influenza A virus detection assay to be appropriate for the novel A(H7N9) viruses. Twenty-two countries reported having containment facilities suitable for its isolation and propagation. Laboratories in 27 countries had applied specific H7 real-time RT-PCR assays and 20 countries had N9 assays in place. Positive control virus RNA was provided by the WHO Collaborating Centre in London to 34 laboratories in 22 countries to allow evaluation of their assays. Performance of the generic influenza A virus detection and H7 and N9 subtyping assays was good in 24 laboratories in 19 countries. The survey showed that ERLI-Net laboratories had rapidly developed and verified good capability to detect the novel A(H7N9) influenza viruses.


2007 ◽  
Vol 0 (0) ◽  
pp. 071018031443009-??? ◽  
Author(s):  
Y.Y. Lu ◽  
J.Y. Yan ◽  
Y. Feng ◽  
C.P. Xu ◽  
W. Shi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document